Ellen P. Woon - Publications
Affiliations: | Emory University, Atlanta, GA |
Area:
decision making, neurotrophins, trkb, medial orbitofrontal cortexYear | Citation | Score | |||
---|---|---|---|---|---|
2022 | Woon EP, Butkovich LM, Peluso AA, Elbasheir A, Taylor K, Gourley SL. Medial orbitofrontal neurotrophin systems integrate hippocampal input into outcome-specific value representations. Cell Reports. 40: 111334. PMID 36103822 DOI: 10.1016/j.celrep.2022.111334 | 0.506 | |||
2021 | Gourley SL, Srikanth KD, Woon EP, Gil-Henn H. Pyk2 Stabilizes Striatal Medium Spiny Neuron Structure and Striatal-Dependent Action. Cells. 10. PMID 34943950 DOI: 10.3390/cells10123442 | 0.623 | |||
2021 | Trinoskey-Rice GE, Woon EP, Pitts EG, Gourley SL. Cocaine Elevates Calcium-Dependent Activator Protein for Secretion 2 in the Mouse Orbitofrontal Cortex. Developmental Neuroscience. 43: 376-382. PMID 34695821 DOI: 10.1159/000519681 | 0.56 | |||
2021 | Whyte AJ, Trinoskey-Rice G, Davies RA, Woon EP, Foster SL, Shapiro LP, Li DC, Srikanth KD, Gil-Henn H, Gourley SL. Cell adhesion factors in the orbitofrontal cortex control cue-induced reinstatement of cocaine seeking and amygdala-dependent goal seeking. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 34074735 DOI: 10.1523/JNEUROSCI.0781-20.2021 | 0.633 | |||
2019 | Woon EP, Seibert TA, Urbanczyk PJ, Ng KH, Sangha S. Differential effects of prior stress on conditioned inhibition of fear and fear extinction. Behavioural Brain Research. 112414. PMID 31891742 DOI: 10.1016/J.Bbr.2019.112414 | 0.519 | |||
2019 | Woon EP, Sequeira MK, Barbee BR, Gourley SL. Involvement of the rodent prelimbic and medial orbitofrontal cortices in goal-directed action: A brief review. Journal of Neuroscience Research. PMID 31820488 DOI: 10.1002/Jnr.24567 | 0.649 | |||
2019 | Pitts EG, Barfield ET, Woon EP, Gourley SL. Action-Outcome Expectancies Require Orbitofrontal Neurotrophin Systems in Naïve and Cocaine-Exposed Mice. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 31218603 DOI: 10.1007/s13311-019-00752-1 | 0.627 | |||
Show low-probability matches. |